Claims data show regorafenib is prescribed earlier than guidelines advise for a good share of patients with advanced GIST, with dosing also varying widely.
|Articles|March 19, 2020
COA to Present Virtual Conference Due to Coronavirus
Author(s)Mary Caffrey
“These are times of unprecedented and unimaginable challenges for our health care system."
Advertisement
The Community Oncology Alliance (COA) will present its annual Community Oncology Conference in a virtual format April 23-24, 2020, to join global efforts to stop the spread of COVID-19 (coronavirus).
“These are times of unprecedented and unimaginable challenges for our health care system,” board members said in a letter today. “We have made the obvious decision to cancel the in-person conference.”
The letter said updates on
Advertisement
Related to this article
ASCOLT finds no overall adjuvant aspirin benefit in colorectal cancer, but meta-analysis links improved disease-free survival to PIK3CA exon 9/20 mutations.
Logistic regression beats machine learning to predict autoimmune hepatitis recurrence after liver transplantation.
A new blood test for adults as young as 40 years arrives as employers and insurers still treat Alzheimer disease as an old-age condition.
Itch and skin appearance outranked safety for 300 US adults with chronic hand eczema, but cancer risk came next.
Rebisufligene etisparvovec-hopf (Fayuvi; Ultragenyx) is a 1-time gene therapy that addresses the underlying cause of Sanfilippo syndrome type A.
Systematic review finds no ready blood biomarkers for psoriasis biologics, but IL-17A/IL-17F and beta-defensin 2 show promise for precision medicine.
Oral GLP-1s, Medicare access, and lingering weight bias are reshaping obesity care, says NYU Langone's Holly Lofton, MD.
Advertisement
Advertisement